The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment
Open accessAbstract
Angiogenesis is the process through which novel blood vessels are formed from pre-existing ones and it is involved in both physiological and pathological processes of the body. Furthermore, tumor angiogenesis is a crucial factor associated with tumor growth, progression, and metastasis. In this manner, there has been a great interest in the development of anti-angiogenesis strategies that could inhibit tumor vascularization. Conventional approaches comprise the administration of anti-angiogenic drugs that target and block the activity of proangiogenic factors. However, as their efficacy is still a matter of debate, novel strategies have been focusing on combining anti-angiogenic agents with chemotherapy or immunotherapy. Moreover, nanotechnology has also been investigated for the potential of nanomaterials to target and release anti-angiogenic drugs at specific sites. The aim of this paper is to review the mechanisms involved in angiogenesis and tumor vascularization and provide an overview of the recent trends in anti-angiogenic strategies for cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
Fukumura, D., Kloepper, J., Amoozgar, Z., Duda, D. G., & Jain, R. K. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.29 · Cited by 2,027
Microenvironmental regulation of tumour angiogenesis
De Palma, M., Biziato, D., & Petrova, T. V. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.51 · Cited by 1,847
Pujade-Lauraine, E., Hilpert, F., Weber, B., Reuss, A., Poveda, A., Kristensen, G., Sorio, R., Vergote, I., Witteveen, P., Bamias, A., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.4489 · Cited by 1,622
Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis.
Melincovici, C. S., Boşca, A. B., Șușman, S., Mărginean, M. V., Mihu, C., Istrate, M., Moldovan, I. M., Roman, A. L., & Mihu, C. M. (2018) · PubMed · Cited by 1,146
Robert, N. J., Diéras, V., Glaspy, J., Brufsky, A. M., Bondarenko, I., Lipatov, O. N., Perez, E. A., Yardley, D. A., Chan, S. Y. T., Zhou, X., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.0982 · Cited by 1,064
Miles, D. W., Chan, A., Dirix, L. Y., Cortés, J., Pivot, X., Tomczak, P., Delozier, T., Sohn, J. H., Provencher, L., Puglisi, F., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.6457 · Cited by 897
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
Tian, L., Goldstein, A., Wang, H., Ching Lo, H., Sun Kim, I., Welte, T., Sheng, K., Dobrolecki, L. E., Zhang, X., Putluri, N., et al. (2017) · Nature · doi:10.1038/nature21724 · Cited by 841
Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation
Allen, E., Jabouille, A., Rivera, L. B., Lodewijckx, I., Missiaen, R., Steri, V., Feyen, K., Tawney, J., Hanahan, D., Michael, I. P., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aak9679 · Cited by 820
Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
Khan, K. A., & Kerbel, R. S. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.9 · Cited by 657
The Role of Angiogenesis in Cancer Treatment
Rajabi, M., & Mousa, S. (2017) · Biomedicines · doi:10.3390/biomedicines5020034 · Cited by 656
Vascularization and Angiogenesis in Tissue Engineering: Beyond Creating Static Networks
Rouwkema, J., & Khademhosseini, A. (2016) · Trends in Biotechnology · doi:10.1016/j.tibtech.2016.03.002 · Cited by 651
Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment
Yi, M., Jiao, D., Qin, S., Chu, Q., Wu, K., & Li, A. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0974-6 · Cited by 608
Zimna, A., & Kurpisz, M. (2015) · BioMed Research International · doi:10.1155/2015/549412 · Cited by 604
Molecular Basis for the Regulation of Angiogenesis by Thrombospondin-1 and -2
Lawler, P. R., & Lawler, J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006627 · Cited by 532
Anti-VEGF/VEGFR Therapy for Cancer: Reassessing the Target
Sitohy, B., Nagy, J. A., & Dvorak, H. F. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3406 · Cited by 360
Aghajanian, C., Goff, B., Nycum, L. R., Wang, Y. V., Husain, A., & Blank, S. V. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.08.004 · Cited by 320
Chemotherapy and Dietary Phytochemical Agents
Sak, K. (2012) · Chemotherapy Research and Practice · doi:10.1155/2012/282570 · Cited by 310
Gray, R., Bhattacharya, S., Bowden, C., Miller, K., & Comis, R. L. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.6630 · Cited by 294
MTOR inhibitors in cancer therapy
Xie, J., Wang, X., & Proud, C. G. (2016) · F1000Research · doi:10.12688/f1000research.9207.1 · Cited by 266
Loges, S., Schmidt, T., & Carmeliet, P. (2010) · Genes & Cancer · doi:10.1177/1947601909356574 · Cited by 257
Platelets and cancer angiogenesis nexus
Wojtukiewicz, M. Z., Sierko, E., Hempel, D., Tucker, S. C., & Honn, K. V. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9673-1 · Cited by 257
Manegold, C., Dingemans, A.-M. C., Gray, J. E., Nakagawa, K., Nicolson, M., Peters, S., Reck, M., Wu, Y.-L., Brustugun, O. T., Crinò, L., et al. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.10.003 · Cited by 242
Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics
Abdalla, A. M. E., Xiao, L., Ullah, M. W., Yu, M., Ouyang, C., & Yang, G. (2018) · Theranostics · doi:10.7150/thno.21674 · Cited by 240
Tumor angiogenesis and anti‑angiogenic gene therapy for cancer (Review)
Li, T., Kang, G., Wang, T., & Huang, H. (2018) · Oncology Letters · doi:10.3892/ol.2018.8733 · Cited by 240
Hypoxia-Inducible Factor as an Angiogenic Master Switch
Hashimoto, T., & Shibasaki, F. (2015) · Frontiers in Pediatrics · doi:10.3389/fped.2015.00033 · Cited by 231
Regulation of tumor angiogenesis by thrombospondin-1
Ren, B., Yee, K. O., Lawler, J., & Khosravi-Far, R. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.11.002 · Cited by 225
Anti-Angiogenics: Current Situation and Future Perspectives
Zirlik, K., & Duyster, J. (2018) · Oncology Research and Treatment · doi:10.1159/000488087 · Cited by 216
The Great Escape; the Hallmarks of Resistance to Antiangiogenic Therapy
van Beijnum, J. R., Nowak-Sliwinska, P., Huijbers, E. J. M., Thijssen, V. L., & Griffioen, A. W. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.010215 · Cited by 211
Lan, C.-Y., Wang, Y., Xiong, Y., Li, J.-D., Shen, J.-X., Li, Y.-F., Zheng, M., Zhang, Y.-N., Feng, Y.-L., Liu, Q., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30349-8 · Cited by 189
Tumor microenvironment: Interactions and therapy
Najafi, M., Goradel, N. H., Farhood, B., Salehi, E., Solhjoo, S., Toolee, H., Kharazinejad, E., & Mortezaee, K. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27425 · Cited by 185
Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis
Kowalska, M. A., Rauova, L., & Poncz, M. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2009.11.023 · Cited by 184
Dehghani, S., Nosrati, R., Yousefi, M., Nezami, A., Soltani, F., Taghdisi, S. M., Abnous, K., Alibolandi, M., & Ramezani, M. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2018.03.037 · Cited by 181
Therapeutic application of anti-angiogenic nanomaterials in cancers
Mukherjee, S., & Patra, C. R. (2016) · Nanoscale · doi:10.1039/c5nr07887c · Cited by 169
Emerging Roles for VEGF-D in Human Disease
Stacker, S., & Achen, M. (2018) · Biomolecules · doi:10.3390/biom8010001 · Cited by 166
The Impact of the Immune System on Tumor: Angiogenesis and Vascular Remodeling
Stockmann, C., Schadendorf, D., Klose, R., & Helfrich, I. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00069 · Cited by 163
Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels
Rauniyar, K., Jha, S. K., & Jeltsch, M. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00007 · Cited by 154
Vascular Cells in Blood Vessel Wall Development and Disease
Mazurek, R., Dave, J. M., Chandran, R. R., Misra, A., Sheikh, A. Q., & Greif, D. M. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2016.08.001 · Cited by 153
The Role of PDGFs and PDGFRs in Colorectal Cancer
Manzat-Saplacan, R. M., Bălăcescu, L., Gherman, C. D., Chira, R. I., Anca, C., Mircea, P. A., Lisencu, C. I., & Bălăcescu, O. (2017) · Mediators of Inflammation · doi:10.1155/2017/4708076 · Cited by 151
VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease
Barratt, S. L., Flower, V., Pauling, J. D., & Millar, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051269 · Cited by 145
Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengers
Poluzzi, C., Iozzo, R. V., & Schaefer, L. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.012 · Cited by 136
Modelling skin wound healing angiogenesis: A review
Guerra, A., Belinha, J., & Jorge, R. N. (2018) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2018.09.020 · Cited by 119
Targeting VEGF pathway to normalize the vasculature: an emerging insight in cancer therapy
Wu, J., Tang, Y., & Liang, X. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s172042 · Cited by 116
Angiogenesis in Pancreatic Cancer: Pre-Clinical and Clinical Studies
Annese, T., Tamma, R., Ruggieri, S., & Ribatti, D. (2019) · Cancers · doi:10.3390/cancers11030381 · Cited by 110
Loizzi, V., Vecchio, V. D., Gargano, G., Liso, M. D., Kardashi, A., Naglieri, E., Resta, L., Cicinelli, E., & Cormio, G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091967 · Cited by 99
Molecular regulation and role of angiogenesis in reproduction
Rizov, M., Andreeva, P., & Dimova, I. I. (2017) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2016.06.019 · Cited by 97
Failla, C. M., Carbo, M., & Morea, V. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051306 · Cited by 95
Isidori, A. M., Venneri, M. A., & Fiore, D. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0502-0 · Cited by 92
Recent advances in anti-angiogenic nanomedicines for cancer therapy
Bhattarai, P., Hameed, S., & Dai, Z. (2018) · Nanoscale · doi:10.1039/c7nr09612g · Cited by 92
The Angiopoietin-Tie2 Signaling Axis in Systemic Inflammation
Parikh, S. M. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017010069 · Cited by 90
Pro‐ and antiangiogenic therapies: current status and clinical implications
Rust, R., Gantner, C., & Schwab, M. E. (2018) · The FASEB Journal · doi:10.1096/fj.201800640rr · Cited by 86
Molecular Regulation of Sprouting Angiogenesis
Duran, C. L., Howell, D. W., Dave, J. M., Smith, R. L., Torrie, M. E., Essner, J. J., & Bayless, K. J. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160048 · Cited by 86
Angiogenesis in peripheral arterial disease
Inampudi, C., Akintoye, E. O., Ando, T., & Briasoulis, Α. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.02.011 · Cited by 82
Lord, M. S., Cheng, B., Farrugia, B. L., McCarthy, S. J., & Whitelock, J. M. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.760660 · Cited by 81
Wise, L. M., Inder, M. K., Real, N. C., Stuart, G. S., Fleming, S. B., & Mercer, A. A. (2012) · Cellular Microbiology · doi:10.1111/j.1462-5822.2012.01802.x · Cited by 79
Targeting hypoxia-inducible factor 1 to stimulate tissue vascularization
Semenza, G. L. (2015) · Journal of Investigative Medicine · doi:10.1097/jim.0000000000000206 · Cited by 76
Molecular Mechanisms for Exercise Training-Induced Changes in Vascular Structure and Function
Olver, T. D., Ferguson, B. S., & Laughlin, M. H. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.07.017 · Cited by 75
Vascular endothelial growth factor and diabetic macular edema
Lally, D. R., Shah, C. P., & Heier, J. S. (2016) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2016.03.010 · Cited by 74
Angiopoietins and diabetic nephropathy
Gnudi, L. (2016) · Diabetologia · doi:10.1007/s00125-016-3995-3 · Cited by 70
Patzelt, J., & Langer, H. F. (2012) · Current Vascular Pharmacology · doi:10.2174/157016112801784648 · Cited by 68
The Role of Fibrinolytic Regulators in Vascular Dysfunction of Systemic Sclerosis
Kanno, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030619 · Cited by 66
Li, W., Quan, Y., Li, Y., Lu, L., & Cui, M. (2018) · Cancer Management and Research · doi:10.2147/cmar.s174712 · Cited by 65
The Role of Angiogenesis and Pro-Angiogenic Exosomes in Regenerative Dentistry
Zimța, A., Baru, O., Badea, M. E., Buduru, S. D., & Berindan‐Neagoe, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020406 · Cited by 62
Therapeutic angiogenesis: From conventional approaches to recent nanotechnology-based interventions
Augustine, R., Prasad, P., & Khalaf, I. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.01.006 · Cited by 61
A Structural Atlas of Kinases Inhibited by Clinically Approved Drugs
Wang, Q., Zorn, J. A., & Kuriyan, J. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-397918-6.00002-1 · Cited by 57
Mahfouz, N., Tahtouh, R., Alaaeddine, N., Hajj, J. E., Sarkis, R., Hachem, R. Y., RAAD, I. I., & Hilal, G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179202 · Cited by 57
Platelet-derived growth factor-C and -D in the cardiovascular system and diseases
Lee, C., & Li, X. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.09.005 · Cited by 57
Important signals regulating coronary artery angiogenesis
Shoeibi, S., Mozdziak, P. E., & Mohammadi, S. (2017) · Microvascular Research · doi:10.1016/j.mvr.2017.12.002 · Cited by 54
Current therapies and investigational drugs for peripheral arterial disease
Suzuki, J.-I., Shimamura, M., Suda, H., Wakayama, K., Kumagai, H., Ikeda, Y., Akazawa, H., Isobe, M., Komuro, I., & Morishita, R. (2015) · Hypertension Research · doi:10.1038/hr.2015.134 · Cited by 53
Acquired tumor resistance to antiangiogenic therapy: Mechanisms at a glance
Zarin, B., Zarifi, F., Vaseghi, G., & Javanmard, S. H. (2017) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_182_17 · Cited by 53
Laakkonen, J. P., Lähteenvuo, J., Jauhiainen, S., Heikura, T., & Ylä‐Herttuala, S. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2018.10.005 · Cited by 52
Enzymes involved in tumor-driven angiogenesis: A valuable target for anticancer therapy
Ricciuti, B., Foglietta, J., Bianconi, V., Sahebkar, A., & Pirro, M. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.11.005 · Cited by 50
Kato, T. (2017) · Biomedical Reports · doi:10.3892/br.2017.1001 · Cited by 49
Alidzanovic, L., Starlinger, P. P., Schauer, D., Maier, T. H. P., Feldman, A., Buchberger, E., Stift, J., Köck, U., Pop, L., Gruenberger, B., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11084 · Cited by 48
Yang, J., Wang, L., & Dong-chu, M. (2017) · British Journal of Haematology · doi:10.1111/bjh.15000 · Cited by 47
Yonucu, S., Yιlmaz, D., Phipps, C., Unlu, M. B., & Kohandel, M. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005724 · Cited by 46
Feng, T., Yu, H., Xia, Q., Ma, Y., Yin, H., Shen, Y., & Liu, X. (2017) · Oncotarget · doi:10.18632/oncotarget.18632 · Cited by 43
Logue, O. C., McGowan, J. W. D., George, E. M., & Bidwell, G. L. (2016) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000256 · Cited by 36
Therapeutic Angiogenesis: Angiogenic Growth Factors for Ischemic Heart Disease
Henning, R. J. (2016) · Future Cardiology · doi:10.2217/fca-2016-0006 · Cited by 35
Qin, R., Zhang, Z., Zhu, N., Chen, F., Guo, Q., Hu, H.-W., Fu, S., Liu, S., Chen, Y., Fan, J., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4738-2 · Cited by 33
Ren, B., Rose, J. B., Liu, Y., Jaskula‐Sztul, R., Contreras, C. M., Beck, A. W., & Chen, H. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111980 · Cited by 33
Vasculogenesis and Its Cellular Therapeutic Applications
Ratajska, A., Jankowska-Steifer, E. A., Czarnowska, E., Olkowski, R., Gula, G., Niderla‐Bielińska, J., Flaht‐Zabost, A., & Jasińska-Nowacka, A. (2016) · Cells Tissues Organs · doi:10.1159/000448551 · Cited by 32
Repsold, L., Pool, R., Karodia, M., Tintinger, G. R., & Joubert, A. M. (2017) · Cancer Cell International · doi:10.1186/s12935-017-0460-4 · Cited by 32
Current Trends in Cancer Therapy
Sekhon, N., Kumbla, R. A., & Mita, M. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803547-4.00001-x · Cited by 30
Angiogenic growth factors in myocardial infarction: a critical appraisal
Hemalatha, T., Umamaheswari, T., Shanmugham, I., Gunadharini, D. N., & Kaliyaperumal, A. (2017) · Heart Failure Reviews · doi:10.1007/s10741-017-9630-7 · Cited by 29
Endogenous Antiangiogenic Factors in Chronic Kidney Disease: Potential Biomarkers of Progression
Tanabe, K., Sato, Y., & Wada, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071859 · Cited by 29
Anti-angiogenic isoform of vascular endothelial growth factor-A in cardiovascular and renal disease
Kikuchi, R., Stevens, M., Harada, K., Oltean, S., & Murohara, T. (2018) · Advances in clinical chemistry · doi:10.1016/bs.acc.2018.10.001 · Cited by 29
Angiogenesis and Anti-Angiogenesis Strategies in Cancer
Mousa, S. A., & Davis, P. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802576-5.00001-2 · Cited by 24
Rapalino, O., Batchelor, T. T., & González, R. G. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53485-9.00014-3 · Cited by 24
Platelet-Derived Growth Factor in Heart Failure
Medamana, J. L., Clark, R. A. F., & Butler, J. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_80 · Cited by 23
Nanotherapeutic approaches targeting angiogenesis and immune dysfunction in tumor microenvironment
Hameed, S., Bhattarai, P., & Dai, Z. (2018) · Science China Life Sciences · doi:10.1007/s11427-017-9256-1 · Cited by 21
Aichouchi, A. E., & Gorry, P. (2018) · Scientometrics · doi:10.1007/s11192-018-2752-4 · Cited by 21
Angiogenic factors: role in esophageal cancer, a brief review
Ladeira, K., Macedo, F., Longatto‐Filho, A., & Martins, S. F. F. (2017) · Esophagus · doi:10.1007/s10388-017-0597-1 · Cited by 20
Li, Y., Huang, P., Peng, H., Yue, H., Wu, M., Liu, S., Qin, R., Fan, J., & Han, Y. (2019) · Cancer Management and Research · doi:10.2147/cmar.s192868 · Cited by 18
VEGF-Mediated Signal Transduction in Tumor Angiogenesis
Napione, L., Alvaro, M., & Bussolino, F. (2017) · InTech eBooks · doi:10.5772/66764 · Cited by 15
Zhao, S., Jiang, T., Li, X., & Zhou, C. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.11.293 · Cited by 12
Cardiovascular System: Structure, Assessment, and Diseases
Padsalgikar, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35885-9.00005-9 · Cited by 12
Commentary on Folkman: “Tumor Angiogenesis Factor”
Bagley, R. G. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0675 · Cited by 11
Capillary dynamics, interstitial fluid and the lymphatic system
Haggerty, A., & Nirmalan, M. (2019) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2019.01.009 · Cited by 11
Bioengineering of FGFs and New Drug Developments
Li, X. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-816142-5.00008-4 · Cited by 9
REGULATION OF CELL BEHAVIOR BY MATRICELLULAR PROTEINS
Bradshaw, A. D., & Sage, E. H. (2000) · Elsevier eBooks · doi:10.1016/b978-012436630-5/50015-5 · Cited by 8
Organofluorine Compounds as Anticancer Agents
Reddy, V. P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53748-5.00009-5 · Cited by 7
Targeted Therapy and Molecular Genetics
Westin, S. N., Sood, A. K., & Coleman, R. L. (2012) · Elsevier eBooks · doi:10.1016/b978-0-323-07419-3.00018-7 · Cited by 6
Tumor Angiogenesis: A Focus on the Role of Cancer Stem Cells
Fujita, K., & Akita, M. (2017) · InTech eBooks · doi:10.5772/66402 · Cited by 6
Grant, M. A., & Karsan, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00123-2 · Cited by 6
Inhibitors of corneal inflammation and angiogenesis : Prospectives and challenges
Mirabelli, P. (2019) · Linköping University medical dissertations · doi:10.3384/diss.diva-156415 · Cited by 5
HGF Gene Therapy for Therapeutic Angiogenesis in Peripheral Artery Disease
Muratsu, J., Sanada, F., Taniyama, Y., Ikeda-Iwabu, Y., Otsu, R., Shibata, K., Brulé, M. K., Rakugi, H., & Morishita, R. (2017) · Springer eBooks · doi:10.1007/978-981-10-2744-4_9 · Cited by 4
Tumor angiogenesis gets nervous
Kiberstis, P. A. (2017) · Science · doi:10.1126/science.358.6361.316-g · Cited by 4
Mousa, S. A., Sudha, T., & Davis, P. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802576-5.00010-3 · Cited by 3
Vascular Growth in Health and Disease
Rak, J. W. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00015-9 · Cited by 3
Multimodality Targeting of Glioma Cells
He, Z., Mitteer, R. A., Mou, Y., & Fan, Y. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-47660-7.00005-7 · Cited by 3
Fibroblast Growth Factor in Extremities
Tanaka, M., & Yonemitsu, Y. (2017) · Springer eBooks · doi:10.1007/978-981-10-2744-4_10 · Cited by 1
Kareva, I. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813673-7.00004-5 · Cited by 1
Cited by
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
Zhong, L., Li, Y., Xiong, L., Wang, W., Wu, M., Yuan, T., Yang, W., Tian, C., Miao, Z., Wang, T., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00572-w · Cited by 1,696
Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets
Wang, B., Wu, L., Chen, J., Dong, L., Chen, C., Wen, Z., Hu, J., Fleming, I., & Wang, D. W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00443-w · Cited by 1,414
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
Liu, Z.-L., Chen, H.-H., Zheng, L.-L., Sun, L.-P., & Shi, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01460-1 · Cited by 1,300
The role of microenvironment in tumor angiogenesis
Jiang, X., Wang, J., Deng, X., Xiong, F., Zhang, S., Gong, Z., Li, X., Cao, K., Deng, H., He, Y., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01709-5 · Cited by 761
Interferon-γ: teammate or opponent in the tumour microenvironment?
Gocher, A. M., Workman, C. J., & Vignali, D. A. A. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00566-3 · Cited by 582
Metadata
- Authors
- Teleanu, R. I., Chircov, C., Grumezescu, A. M., & Teleanu, D. M.
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2019-12-29
- Volume
- 9
- Issue
- 1
- Pages
- 84
- ISSN
- 2077-0383 (ISSN-L)
- OpenAlex
- W2997891042
- Cited by
- 503
- References
- 112
- FWCI
- 15.90
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.